Advocacy - HOSP

HOSP Perspectives

Home Infusion Endorsement Letters to the House and Senate

Zach Dake2025-03-19T14:43:23-04:00March 19th, 2025|

The HOSP Alliance remains steadfast in its commitment to improved patient outcomes and advocating for industry best practices that [...]

HOSP Senate 340B Working Group RFI Response

Zach Dake2024-04-03T18:33:27-04:00April 3rd, 2024|

HOSP continues to advocate for support of the 340B program for its members. On April 01, HOSP submitted comments [...]

HOSP Comments on Senate 340B Working Group

Jessica Carvalho2023-10-03T13:51:29-04:00October 3rd, 2023|

HOSP continues to advocate for support of the 340B program for its members. On July 28, HOSP submitted comments [...]

HOSP stands against the most recent restrictions implemented by Johnson & Johnson

[email protected]2023-03-13T15:33:33-04:00March 13th, 2023|

HOSP stands against the most recent restrictions implemented by Johnson & Johnson that will severely limit access to 340B discounts [...]

February 2023 testimony for the New York Health Hearing Budget

[email protected]2023-03-01T14:21:35-05:00March 1st, 2023|

Health System Owned Specialty Pharmacy Alliance (HOSP) is a network of leading health systems and the businesses that support [...]

HOSP Letters to AM Paulin and Senator Rivera

Max Zhou2023-02-17T22:40:39-05:00February 17th, 2023|

The HOSP Alliance remains steadfast in its commitment to improved patient outcomes and advocating for industry best practices that [...]

12 Next

The Health System Owned Specialty Pharmacy Alliance supports and endorses the Health Services and Resource Administration’s decision in support of 340B and the covered entities that care for the millions of Americans that benefit from this life-saving program. This is a resounding victory for patients, and HOSP thanks 340B Health for its tireless advocacy. HOSP will continue to support the 340B Program as a critical component in U.S. healthcare, particularly for its role in health equity and patient choice.